Another Short Seller Twitter Hoax Hits a High Flying Stock (SRPT) (ADNC)

January 30, 2013 11:34 AM EST
Trading fraudsters are at it again Wednesday.

Shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) fell out of bed mid-day after a Twitter account posing to be influential short selling firm Citron Research made a negative mention of the stock. The stock fell as much as 10 percent before recovering. Shares last traded up 3.5% to $28.13.

"$SRPT FDA steps in as its 48 weeks results on Eteplirsen results are tainted and have been doctored they believeTrial papers seized by FDA."

Twitter has since suspended this account.

A similar occurrence happened Tuesday when a Twitter account posing as Muddy Waters Research issued a tweet about Audience (NASDAQ: ADNC). The real Muddy Waters called it a "hoax." Shares of Audience plunged 24% intra-day before recovering and closing up 4.5%.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Insiders' Blog, Trader Talk

Related Entities

Twitter, Citron Research, Muddy Waters LLC

Add Your Comment